Browse the evidence

In women with PCOS, the risk of Type 2 Diabetes Mellitus (T2DM) is primarily driven by overweight and obesity rather than the syndrome itself; normal-weight women with PCOS do not have an increased risk of T2DM or prediabetes.

If you have PCOS, your weight is the most critical factor in your diabetes risk. If you are overweight or obese, you are at significantly higher risk, but this risk is driven by the weight, not just the PCOS diagnosis. If you are normal weight, your risk of developing Type 2 Diabetes is not significantly higher than women without PCOS. Focus on maintaining a healthy weight, especially during early adulthood, as this is the most effective way to prevent diabetes in PCOS.

Metabolically normal obese (MNO) individuals, defined by low intrahepatic triglyceride content, are protected from adverse metabolic effects such as insulin resistance and dyslipidemia following moderate weight gain, unlike metabolically abnormal obese (MAO) individuals.

If you are obese but have low liver fat (metabolically normal), moderate weight gain is unlikely to trigger diabetes or heart disease risks. However, if you have high liver fat (metabolically abnormal), even small weight gains can significantly worsen your metabolic health. Focus on liver fat reduction (via diet/exercise) rather than just weight loss if you are in the metabolically abnormal group.

Caloric restriction via a hypocaloric protein diet reduces blood pressure in obese patients by lowering sympathetic nervous system activity (norepinephrine levels) and suppressing the renin-angiotensin-aldosterone axis.

For obese individuals with hypertension, a short-term, medically supervised very-low-calorie protein diet (approx. 320 kcal/day) can significantly lower blood pressure by reducing sympathetic nervous system activity and renin-angiotensin-aldosterone levels, independent of sodium intake. This suggests that caloric deficit itself, rather than just salt reduction, drives blood pressure improvements in obesity.

Consuming a higher percentage of daily caloric intake at dinner (specifically the highest tertile, ≥48% of daily kcal) significantly increases the risk of developing obesity, metabolic syndrome, and non-alcoholic fatty liver disease (NAFLD) over a 6-year period.

If you tend to eat the majority of your daily calories during the evening meal, you may be increasing your risk of obesity and metabolic issues, even if your total daily calorie count is healthy. Try shifting more of your energy intake to earlier in the day (breakfast and lunch) to align with your body's natural metabolic rhythms.

The cognitive benefits of weight loss are stronger in younger seniors (under 70) for memory/fluency and in APOE4 carriers for executive function.

Older adults with MCI who are closer to 60 years old or who carry the APOE4 gene variant may see greater cognitive improvements from weight loss compared to those over 70 or non-carriers.

Lower Free T4 (FT4) levels within the euthyroid range are negatively associated with BMI, waist circumference, and triglycerides, and positively associated with HDL-cholesterol.

While T3 is often the focus, your Free T4 levels also matter. In this study, lower FT4 (within the normal range) was linked to lower body weight and waist size. This highlights that thyroid health is about the balance and ratio of hormones, not just hitting a 'normal' TSH number.

Higher TSH levels within the normal reference range are positively associated with total cholesterol, triglycerides, and blood pressure.

If your TSH is on the higher end of the 'normal' range, it might be contributing to higher blood pressure and cholesterol, even if you don't have hypothyroidism. This suggests that 'normal' TSH might not be 'optimal' for everyone, especially regarding cardiovascular health.

Semaglutide at its maximum tolerated dose (MTD) is associated with the highest odds of treatment discontinuation due to adverse events among all tested regimens, including tirzepatide MTD.

If you choose semaglutide at its maximum dose, be aware that you have the highest statistical risk of stopping the medication due to side effects compared to other options in this study. Monitor your tolerance closely and communicate with your provider immediately if side effects become unmanageable.

Tirzepatide demonstrates cardiovascular safety, with hazard ratios for major adverse cardiovascular events (MACE) remaining below 1.3 compared to pooled comparators, indicating no increased cardiovascular risk.

For patients with heart disease or high risk factors, Tirzepatide has been shown to be safe regarding cardiovascular events. It does not increase the risk of heart attack, stroke, or cardiovascular death compared to standard treatments. This makes it a viable option for those who need effective diabetes management without compromising heart health.

Increasing meal frequency (3 meals + 3 snacks daily) does not promote greater weight loss, fat loss, or appetite control compared to a lower meal frequency (3 meals daily) when total energy intake is equated.

If you are trying to lose weight, you do not need to force yourself to eat 6 small meals a day. Whether you choose to eat 3 meals or 3 meals plus 3 snacks, your weight loss will be the same as long as you consume the same total calories. Choose the pattern that best fits your lifestyle and hunger cues without exceeding your calorie target.

Resting metabolic rate (RMR) reduction following weight loss is driven primarily by the loss of adipose tissue mass and metabolic adaptations, rather than the loss of skeletal muscle mass.

You don't need to obsess over preserving every gram of muscle to stop your metabolism from slowing down. Research shows that losing fat mass itself, along with hormonal shifts (like lower leptin and thyroid hormones), is what actually drives your resting metabolic rate down after weight loss. This means metabolic adaptation is a natural response to losing fat, not just a failure to build muscle. To manage this, focus on sustainable, slower weight loss and personalized strategies that address these hormonal changes, rather than just trying to 'save' muscle.

Loss of the oxygen sensor PHD1 reduces muscle mass by impairing the stability of the leucine sensor LRS, thereby blunting mTORC1 activation specifically in response to leucine.

Maintaining healthy cellular oxygen sensing and nutrient sensor stability (specifically PHD1 and LRS) is crucial for your muscles to respond to protein/leucine intake. This mechanism explains why older adults often experience 'anabolic resistance'—their muscles struggle to build mass from protein because these specific sensors degrade. While you cannot directly 'dose' PHD1, ensuring adequate oxygenation and avoiding chronic metabolic stress may help preserve these sensors.

Chronic overexpression of melanin-concentrating hormone (MCH) in the lateral hypothalamus causes obesity and insulin resistance, with the severity and onset dependent on genetic background and dietary fat intake.

This research highlights that neuropeptides like MCH play a crucial role in regulating hunger and metabolism. While you cannot directly control MCH levels, understanding that your brain's signaling for hunger is biologically driven can help separate 'willpower' issues from physiological signals. The study also underscores that genetic predispositions to obesity can be mitigated or exacerbated by diet quality (specifically fat content) and that individual biological responses vary significantly.

Chronic low-grade inflammation, driven by obesity and ectopic lipid deposition, impairs insulin signaling and beta-cell function through pathways like NF-κB, JNK, and oxidative stress.

Inflammation is not just a symptom of diabetes; it is a cause. Excess fat, especially around organs (ectopic fat), triggers inflammation that blocks insulin from working and damages insulin-producing cells. Managing weight and diet reduces this inflammation.

In patients with diabetes, LDL cholesterol concentration is a poor indicator of cardiovascular risk because it masks an increased number of atherogenic lipoprotein particles (high apoB) and the presence of small, dense LDL particles.

Do not rely solely on your LDL cholesterol number to assess your heart health. In diabetes, your blood may contain many more small, dangerous cholesterol particles than a standard test shows. Ask your doctor about measuring ApoB or Non-HDL cholesterol for a more accurate risk assessment, and follow their advice on statin therapy even if your LDL looks 'normal'.

Type 2 diabetes negates the natural cardiovascular protection typically afforded to premenopausal women, resulting in a 25–50% greater excess risk of incident cardiovascular disease in women compared to men with diabetes.

If you have type 2 diabetes, your risk of heart disease is not lower than a man's, even if you are a woman. Diabetes removes the natural heart protection women usually have. You need to manage blood pressure, lipids, and blood sugar as aggressively as a man would to protect your heart.

Females have higher rates of insulin resistance than males from early childhood through mid-puberty, whereas males exhibit greater insulin resistance during late puberty and adulthood.

Insulin resistance changes differently for boys and girls as they grow. Girls tend to be more insulin resistant during early puberty, while boys become more resistant later. This biological difference contributes to why girls are more prone to type 2 diabetes in youth, while men are more prone in midlife.

Increased intake of starchy vegetables, specifically potatoes, corn, and peas, is positively associated with weight gain, contrasting with non-starchy vegetables.

Be mindful of starchy vegetables like potatoes, corn, and peas. Unlike leafy greens or broccoli, increasing your intake of these specific vegetables is linked to weight gain, likely due to their higher glycemic load. Balance your plate with non-starchy vegetables and moderate portions of starchy ones.

A high Triglyceride-Glucose (TyG) index is positively associated with a higher prevalence of symptomatic coronary artery disease (CAD) in secondary care patients, independent of social, clinical, and behavioral risk factors.

If you are in secondary cardiac care, ask your doctor about your Triglyceride-Glucose (TyG) index. It is a calculated marker of insulin resistance derived from your fasting triglycerides and glucose levels. A high TyG index is a strong predictor of symptomatic heart disease, even if your standard cholesterol numbers look acceptable. Managing this index through lifestyle changes (diet and activity) is crucial for reducing cardiac risk.

In nondiabetic Pima Indians, higher insulin resistance (lower glucose disposal) is associated with a significantly lower rate of weight gain over time compared to insulin-sensitive individuals.

For individuals with high insulin resistance, standard weight loss advice might need to account for metabolic adaptations. This study suggests that insulin resistance might naturally slow down weight gain in some populations, acting as a protective feedback mechanism against extreme obesity, rather than solely driving it. This does not mean insulin resistance is healthy, but it complicates the simple 'high insulin = fat gain' narrative.

Muscle glycogen depletion following exercise increases in vivo insulin-stimulated carbohydrate storage and total glucose disposal (M-value) in glycogen-replete humans, provided no immediate carbohydrate re-feeding occurs.

If your goal is to maximize your body's ability to store glucose as glycogen (a marker of insulin sensitivity) after a workout, try not to eat carbohydrates immediately after exercising. However, if you prioritize performance or recovery, eating carbs is still beneficial and does not make the exercise 'useless'; it just means you won't get this specific metabolic boost.

Beta-adrenergic receptor blockade with propranolol significantly reduces the thermic effect of glucose and the energy cost of glucose storage in healthy men, indicating that sympathetic nervous system activity drives the facultative component of diet-induced thermogenesis.

Your body burns extra calories after eating carbs partly because your nervous system gets activated by insulin. Blocking this nervous system response (as done in this study with propranolol) significantly reduces that extra calorie burn, bringing it down to the basic energy cost of storing glucose as glycogen. This suggests that the 'thermic effect' of food is not just a chemical cost of storage, but an active neural process.

Acute post-exercise myofibrillar protein synthesis (MPS) rates measured in untrained individuals are not correlated with long-term resistance training-induced muscle hypertrophy.

Do not use your acute muscle protein synthesis response (or how 'pumped' you feel) to predict your long-term muscle growth potential. High acute MPS does not guarantee high hypertrophy, and low acute MPS does not mean you won't grow. Focus on consistent progressive overload over 16+ weeks rather than optimizing for the immediate post-workout metabolic spike.

Immobilization significantly reduces the phosphorylation of mTOR at 48 hours, indicating early suppression of anabolic signaling, which correlates with the down-regulation of PGC-1alpha and mitochondrial biogenesis.

Early in immobilization, your body's primary anabolic signaling (mTOR) is suppressed, which likely contributes to the shutdown of mitochondrial function. This suggests that early nutritional or pharmacological interventions targeting mTOR might be most effective in preserving metabolic health during the first few days of inactivity.